Table 1.
Agent(s) | MIC/MBC (μg/ml) |
|||||
---|---|---|---|---|---|---|
Without sebum (n = 16 isolates) |
With 50% sebum (n = 16 isolates) |
|||||
90% | 50% | Range | 90% | 50% | Range | |
NB-003 | 0.5/2 | 0.5/2 | 0.25–1/0.5–2 | 128/1,024 | 128/1,024 | 64–256/256–1,024 |
NB-003 gel | 1/2 | 0.5/21 | 0.5–1/1–4 | 128/1,024 | 128/1,024 | 64–256/128–>1,024 |
Erythromycin | 1,000/>1,000 | 4/>1,000 | ≤0.25–>1,000/62.5–>1,000 | 1,000/>1,000 | 4/1,000 | ≤0.25–>1,000/62.5–>1,000 |
Clindamycin | 500/>1,000 | 4/1,000 | ≤0.125–500/125–>1,000 | 500/>1,000 | 1/100 | ≤0.125–500/62.5–>1,000 |
Tetracycline | 31/1,000 | 0.5/250 | ≤0.063–31.3/31.3–1,000 | 31.3/1,000 | 0.5/250 | ≤0.063–31.3/31.3–1,000 |
Benzoyl peroxide | 50/200 | 50/200 | ≤50–100/100–400 | 400/1,600 | 200/800 | ≤50–400/800–1,600 |
Salicylic acid | 1,000/2,000 | 1,000/2,000 | 50–1,000/2,000–>2,000 | 1,000/2,000 | 1,000/2,000 | 500–1,000/2,000–>2,000 |
0.3% NB-003 gel + 0.5% BPO | 0.5/4 | 0.5/4 | 0.5–1/2–4 | 128/256 | 128/128 | 128/128–256 |
0.3% NB-003 gel + 2% salicylic acid | 0.5/2 | 0.5/2 | 0.25–1/0.5–2 | 128/256 | 128/128 | 128/128–256 |